Cranberry Supplement Significantly Reduces Recurrent UTIs in Women
A 6-month randomized, double-blind, placebo-controlled trial published in The American Journal of Clinical Nutrition evaluated the effects of whole cranberry fruit powder in women with recurrent urinary tract infections (UTIs). In the study, 150 women with a history of ≥3 UTIs in the past year or ≥2 in the past 6 months received either 500 mg of whole cranberry powder or placebo daily.
At the end of the trial, women taking cranberry experienced a 52% reduction in culture-confirmed UTIs, and a 51% drop in E. coli-related infections. Symptomatic UTIs with frequency and urgency were reduced by 71%, with a 59% decrease in average total UTIs per participant. No serious adverse events were reported.
These findings align with previous research, including a meta-analysis in the Journal of Nutrition showing a 26% reduced UTI risk in women using cranberry products. The reduction in E. coli suggests cranberry’s anti-adhesive properties in the bladder may be the key mechanism—an important consideration, as E. coli is detectable in most UTI cases, even when cultures are negative.
D-Mannose May Reduce Recurrent UTIs with Minimal Side Effects
A recent systematic review and meta-analysis evaluated the effectiveness of D-mannose in preventing recurrent urinary tract infections (UTIs) in adult women. Researchers screened over 700 studies and included eight that met criteria, focusing on women using D-mannose as an outpatient preventive treatment. Three studies qualified for meta-analysis, including randomized controlled trials and prospective cohort studies.
Results showed that D-mannose significantly reduced UTI recurrence compared to placebo, with a pooled relative risk of 0.23 (95% CI, 0.14–0.37). When compared to antibiotics, D-mannose showed a relative risk of 0.39 (95% CI, 0.12–1.25), suggesting similar protective effects, though study variability was high. Importantly, D-mannose was well tolerated, with only one study reporting mild side effects (8 out of 103 participants experienced diarrhea). Compliance rates were high in the two studies that reported them.
While more high-quality, large-scale trials are needed, this analysis supports D-mannose as a promising, low-risk option for reducing UTI recurrence in women. Its favorable safety profile and potential antibiotic-sparing effect make it an attractive alternative for long-term UTI prevention.